Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON25869Active, not recruiting
Trial of loperamide in fecal incontinence (FI) and encopresis (2 arms), sponsored by AMC Health. Primary endpoints: Encopresis frequency and Rectal function. Started Jan 2003; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON25869.